SALIXIN A/S: Financial statements 2024
CVR: 33776748
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SALIXIN A/S (CVR 33776748) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -345,682 and a net result of DKK 1,051,659 compared with DKK -8,533,789 the year before. Equity in the 2024 report amounted to DKK 18,169. The solvency ratio was 2.6%.
- Gross Profit
- DKK -345,682
- Profit/Loss
- DKK 1,051,659
- Equity
- DKK 18,169
- Total Assets
- DKK 711,085
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -346K | 1.1M | 18K | 0 |
| 2023 | - | -286K | -8.5M | -1M | 1 |
| 2022 | - | 496K | 55K | 4M | 1 |
| 2021 | - | 9.1M | 6.3M | 3.9M | 2 |
| 2020 | - | 70K | -746K | -2.4M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 20, 2024, Ny Vraa A/S is registered as an owner of SALIXIN A/S with an ownership share of 100%.
SALIXIN A/S has published its annual report for 2023. Gross profit came to DKK -285,596, and the net result was DKK -8,533,789.
As of June 5, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of SALIXIN A/S.
As of June 5, 2024, A/S PSE 17 NR. 1056 has stepped down as auditor of SALIXIN A/S.
About SALIXIN A/S
SALIXIN A/S is a Danish company of the type Aktieselskab based in Tylstrup, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Juul Bech. The board consists of Michael Bundgaard (chair), Allan Juul Bech and Louise Bech. The company is owned by Ny Vraa A/S. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343.